Translate
Medicinova, Inc.
About
Medicinova, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
Mar 16 2026
MediciNova to Participate at the 38th Annual ROTH Conference
Jan 29 2026
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
Jan 6 2026
2026 New Year’s Greetings from the CEO
Dec 18 2025
MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy
Recent Videos
Breaking News: MediciNova’s peer-reviewed ibudilast study advances clinical translation #StockMarket
Apr 28, 2026
How to Invest in MediciNova Inc (MNOV) Step by Step
Apr 06, 2026
NEXT BIG MOVE | MNOV STOCK ANALYSIS | MEDICINOVA STOCK
Jan 29, 2026
MediciNova - $MNOV - Ep:045 - Nano Cap Podcast
Jan 19, 2026